Literature DB >> 6933236

Dose response of saccharin in induction of urinary bladder hyperplasias in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.

K Nakanishi, A Hagiwara, M Shibata, K Imaida, M Tatematsu, N Ito.   

Abstract

Studies were made on the dose response of saccharin in the induction of bladder lesions. Inbred F344 rats of both sexes were pretreated with 100 ppm N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) in the drinking water for 4 weeks. Sodium saccharin was given at 50,000, 10,000, 2,000, and 400 ppm in the diet for 32 weeks after BBN administration, and surviving rats were killed at the end of week 36 of the experiment. No increase in incidence of papilloma or cancer was noted in either sex at any dose of saccharin after BBN as compared to levels induced by BBN alone. The incidences of two types of hyperplasia and average number of papillary or nodular hyperplasias per 10 cm of basement membrane were significantly increased in the group receiving 50,000 ppm saccharin as compared to the group given BBN only. None of the incidences or numbers of these lesions were significantly different in any of the other saccharin-treated groups when compared to the group treated with BBN alone except for the incidences of two types of hyperplasias in the female rats dosed with 10,000 ppm saccharin. Dose-response curves showed enhanced hyperplastic responses in both sexes given 2,000--50,000 ppm saccharin. Administration of various doses of saccharin without BBN did not cause any changes in the urinary bladders of rats of either sex. These results show that saccharin enhances the induction of early-stage bladder lesions and that the biologic response demonstrates a dose-response effect.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6933236

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  12 in total

Review 1.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

2.  Effects of intravesical instillation of antitumor drugs on the induction of preneoplastic bladder lesions in rats.

Authors:  M Ohtani; S Fukushima; N Ito; K Koiso; T Niijima
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

3.  The distinct health risk analyses required for genotoxic carcinogens and promoting agents.

Authors:  J H Weisburger; G M Williams
Journal:  Environ Health Perspect       Date:  1983-04       Impact factor: 9.031

4.  Urothelial damage and tumor initiation by urinary metabolites of sodium o-phenylphenate in the urinary bladder of female rats.

Authors:  R Hasegawa; F Furukawa; K Toyoda; H Sato; M Takahashi; Y Hayashi
Journal:  Jpn J Cancer Res       Date:  1990-05

5.  Effect of promoters on incidence of bladder cancer in experimental animal models.

Authors:  R M Hicks
Journal:  Environ Health Perspect       Date:  1983-04       Impact factor: 9.031

6.  Multistage carcinogenesis in the urinary bladder.

Authors:  S M Cohen; R E Greenfield; L B Ellwein
Journal:  Environ Health Perspect       Date:  1983-03       Impact factor: 9.031

7.  Modifying factors in urinary bladder carcinogenesis.

Authors:  N Ito; S Fukushima; T Shirai; K Nakanishi; R Hasegawa; K Imaida
Journal:  Environ Health Perspect       Date:  1983-03       Impact factor: 9.031

8.  Effects of promoters on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in the rat.

Authors:  N Ito; S Fukushima; T Shirai; K Nakanishi
Journal:  Environ Health Perspect       Date:  1983-04       Impact factor: 9.031

9.  The induction of rat bladder cancer by 2-naphthylamine.

Authors:  R M Hicks; R Wright; J S Wakefield
Journal:  Br J Cancer       Date:  1982-10       Impact factor: 7.640

10.  No Promoting Effect of Ethyl Tertiary-butyl Ether (ETBE) on Rat Urinary Bladder Carcinogenesis Initiated with N-Butyl-N-(4-hydroxybutyl)nitrosamine.

Authors:  Akihiro Hagiwara; Norio Imai; Yuko Doi; Mayuko Suguro; Mayumi Kawabe; Fumio Furukawa; Kasuke Nagano; Shoji Fukushima
Journal:  J Toxicol Pathol       Date:  2013-12-26       Impact factor: 1.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.